{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04386993",
            "orgStudyIdInfo": {
                "id": "202004237"
            },
            "organization": {
                "fullName": "Washington University School of Medicine",
                "class": "OTHER"
            },
            "briefTitle": "De-escalated Conformal Radiation Expedited Sequentially With Chemotherapy for Endometrial Cancer",
            "officialTitle": "De-escalated Conformal Radiation Expedited Sequentially With Chemotherapy for Endometrial Cancer (DeCRESCEndo)",
            "acronym": "DeCRESCEndo",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "de-escalated-conformal-radiation-expedited-sequentially-with-chemotherapy-for-endometrial-cancer"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-10",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2020-07-07",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-08-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-08-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2020-05-08",
            "studyFirstSubmitQcDate": "2020-05-08",
            "studyFirstPostDateStruct": {
                "date": "2020-05-13",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-10-23",
            "lastUpdatePostDateStruct": {
                "date": "2023-10-26",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Washington University School of Medicine",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": true,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "The goal of this study is to evaluate short course radiation in the post-operative female pelvis after hysterectomy in stage III-IVA endometrial adenocarcinoma patients, or any stage patients with uterine serous or carcinosarcoma histology. The investigators hypothesize that short course pelvic radiation will have an acute and late grade 3-4 toxicity rate \\< 10%, and patients will benefit from both convenient and effective loco-regional control comparable to the traditional 5-6 weeks of radiation."
        },
        "conditionsModule": {
            "conditions": [
                "Endometrial Cancer"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 25,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "IMRT",
                    "type": "EXPERIMENTAL",
                    "description": "-Five 5-Gy fractions of IMRT will be given to the pelvis with elective simultaneous boost to any suspicious lymph node or residual disease to 30 Gy.\n\n-\\*Brachytherapy boost (at the discretion of the PI) within 2 weeks of radiation therapy completion. Once or twice weekly for three weeks",
                    "interventionNames": [
                        "Radiation: Intensity modulated radiation therapy"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "RADIATION",
                    "name": "Intensity modulated radiation therapy",
                    "description": "Radiation should be delivered over the course of 1-2 weeks (allowing for weekends/holidays).",
                    "armGroupLabels": [
                        "IMRT"
                    ],
                    "otherNames": [
                        "IMRT"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Incidence of acute hematologic, gastrointestinal, and genitourinary adverse events",
                    "timeFrame": "From start of radiation through Day 90"
                },
                {
                    "measure": "Incidence of late hematologic, gastrointestinal, and genitourinary adverse events",
                    "timeFrame": "From Day 91 through month 12"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change in patient-reported urinary and gastrointestinal toxicity as measured by PRO-CTCAE",
                    "description": "* PRO-CTCAE responses are scored from 0 to 4 with 0=Never/Not at all/None and 4=Frequently/Very Much/Very Severe/Almost Constantly\n* Scores for each attribute (frequency, severity and/or interference) will be presented descriptively",
                    "timeFrame": "Baseline, 2 weeks, and 3 months post-completion of radiation"
                },
                {
                    "measure": "Change in patient-reported urinary and gastrointestinal toxicity as measured by bowel/bladder domains of EPIC-26",
                    "description": "* Bladder has 7 questions and bowel has 9 questions\n* The response for each item is standardized to a 0 to 100 scale\n* The standardized values will be averaged for all items within a group to create the summary or subscale score.",
                    "timeFrame": "Baseline, 2 weeks, 3 months, 6 months, and 12 months post-completion of radiation"
                },
                {
                    "measure": "Change in quality of life as measured by FACT-En",
                    "description": "* Questionnaire asking questions about physical well-being, social/family well-being, emotional well-being, functional well-being, and other additional concerns. Answers range from 0 = not at all to 4 = very much. Questions are phrased so that higher numbers indicate a better health state,\n* Scoring is performed through a simple sum of item scores. Each subscale is scored, and a total score is obtained by adding each of the subscale scores.",
                    "timeFrame": "Baseline, 2 weeks, 3 months, 6 months, and 12 months post-completion of radiation"
                },
                {
                    "measure": "Locoregional control",
                    "description": "-Locoregional recurrence is defined as histologic or radiographic evidence of cancer in the previously resected site or regional lymph nodes included in the radiated field.",
                    "timeFrame": "Up to 12 months post-completion of radiation"
                },
                {
                    "measure": "Distant control",
                    "description": "-Distant recurrence is defined as histologic or radiographic evidence of cancer outside of the radiated field.",
                    "timeFrame": "Up to 12 months post-completion of radiation"
                },
                {
                    "measure": "Disease-free survival",
                    "description": "-Disease-free survival is defined as survival with no evidence of disease recurrence or death",
                    "timeFrame": "Up to 12 months post-completion of radiation"
                },
                {
                    "measure": "Overall survival",
                    "description": "-Number of participants alive at the time of completion of follow-up",
                    "timeFrame": "Up to 12 months post-completion of radiation"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Histologically or cytologically confirmed stage IIIA-IVA endometrial cancer, or any stage I-IVA where any proportion of the tumor is uterine serous, clear cell, de-differentiated, or carcinosarcoma histology.\n* Must have already undergone radical hysterectomy. Hysterectomy may have occurred no more than one year prior to enrollment.\n* At least 18 years of age.\n* ECOG performance status \u2264 2\n* Minimal bone marrow and organ function as defined below:\n\n  * Leukocytes \u2265 1,000 cumm\n  * Absolute neutrophil count \u2265 500 cumm\n  * Platelets \u2265 50,000 cumm\n  * Hemoglobin \u2265 7g/dL\n* Ability to understand and willingness to sign an IRB approved written informed consent document (or that of legally authorized representative, if applicable).\n\nExclusion Criteria:\n\n* Prior radiation to the pelvis.\n* Currently receiving any investigational agents.\n* Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, inflammatory bowel disease, or irritable bowel disease.\n* Patients with HIV are eligible unless their CD4+ T-cell counts are \\< 350 cells/mcL or they have a history of AIDS-defining opportunistic infection within the 12 months prior to registration. Concurrent treatment with effective ART according to DHHS treatment guidelines is recommended.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Jessika Contreras, M.D.",
                    "role": "CONTACT",
                    "phone": "314-747-7236",
                    "email": "jcontreras@wustl.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Jessika Contreras, M.D.",
                    "affiliation": "Washington University School of Medicine",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Washington University School of Medicine",
                    "status": "RECRUITING",
                    "city": "Saint Louis",
                    "state": "Missouri",
                    "zip": "63110",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jessika Contreras, M.D.",
                            "role": "CONTACT",
                            "phone": "314-747-7236",
                            "email": "jcontreras@wustl.edu"
                        },
                        {
                            "name": "Jessika Contreras, M.D.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        },
                        {
                            "name": "Stephanie Markovina, M.D., Ph.D.",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Matthew Powell, M.D.",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Yi Huang, M.S.",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Julie Schwarz, M.D., Ph.D.",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Andrea Hagemann, M.D.",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Lindsay Kuroki, M.D.",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "L. Stewart Massad, M.D.",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Carolyn McCourt, M.D.",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "David Mutch, M.D.",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Premal Thaker, M.D.",
                            "role": "SUB_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.62727,
                        "lon": -90.19789
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine",
                    "url": "http://www.siteman.wustl.edu"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "Individual participant data that underlie the results reported in the article, after deidentification (text, tables, figures, and appendices) for individual participant data meta-analysis by investigators whose proposed use of data has been approved by an independent review committee (\"learned intermediary\") identified for this purpose.",
            "infoTypes": [
                "STUDY_PROTOCOL"
            ],
            "timeFrame": "Proposals may be submitted up to 36 months following article publication.",
            "accessCriteria": "Please contact Dr. Alexander Lin at alexanderlin@wustl.edu"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000016889",
                    "term": "Endometrial Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000014594",
                    "term": "Uterine Neoplasms"
                },
                {
                    "id": "D000005833",
                    "term": "Genital Neoplasms, Female"
                },
                {
                    "id": "D000014565",
                    "term": "Urogenital Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000014591",
                    "term": "Uterine Diseases"
                },
                {
                    "id": "D000005831",
                    "term": "Genital Diseases, Female"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000091662",
                    "term": "Genital Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M19235",
                    "name": "Endometrial Neoplasms",
                    "asFound": "Endometrial Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17342",
                    "name": "Uterine Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M8945",
                    "name": "Genital Neoplasms, Female",
                    "relevance": "LOW"
                },
                {
                    "id": "M17315",
                    "name": "Urogenital Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M17339",
                    "name": "Uterine Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8943",
                    "name": "Genital Diseases, Female",
                    "relevance": "LOW"
                },
                {
                    "id": "M2876",
                    "name": "Genital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        }
    },
    "hasResults": false
}